Literature DB >> 17565262

[Biliary tract carcinoma in elderly patients in whom gemcitabine chemotherapy induced complete remission - a report of two cases].

Sayuri Nitta1, Kazuyoshi Nagayama, Yoshinori Sakai, Fumihiko Kusano, Junichi Tazawa.   

Abstract

The authors experienced two patients with biliary tract carcinoma who could not be considered candidates for surgery. One was a 78-year-old female with cholangiocellular carcinoma who presented with acute cholangitis. Tumors had spread to both lobes of the liver, and chemotherapy with gemcitabine (GEM) alone was selected. After three months of treatment, the tumors disappeared radiographically. Disease-free survival has been maintained for 30 months. The second patient was a 79-year-old female with gallbladder carcinoma who presented with acute cholecystitis. Because of her poor cardiac function,GEM single-drug regimen was started. After four months, the tumor had completely disappeared on both computed tomography and ultrasonography. Currently, after 23 months of treatment period, the disease-free survival has persisted. Although GEM was originally applied to non-small cell lung cancer and pancreas cancer, recently, its anti-tumor effect on biliary tract carcinoma has been elucidated, and it is becoming the leader for the first-line regimen. However, the number of patients showing complete remission were still limited.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565262

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1.

Authors:  Joo Hyun Lim; Ji Kon Ryu; Yoon Jin Choi; Jieun Kwon; Ji Yeon Kim; Yun Bin Lee; Jae Hwan Kim; Won Jae Yoon; Yong Tae Kim; Yong Bum Yoon
Journal:  Gut Liver       Date:  2013-05-13       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.